Sellas Life Sciences
- Market cap
- 2.28B
- P/E (TTM)i
- -51.41
- P/Bi
- 16.58
- EPSi
- -0.25
- Div yieldi
- 0.00%
- 52W posi
- 68%
Anonymous reader poll. Unscientific, not investment advice.
Sellas Life Sciences shares were changing hands at 11.31, down 0.26% on the day. At current prices, the business is worth about 2.28B, the #2687 most valuable US-listed company we track. Wall Street's 1-analyst consensus lands on Buy, with a price target averaging 30.00 (+165% from here). The shares sit 68% of the way up their 52-week range of 1.39 to 15.88.
✦ StockVane Quant Insights how this is computed
- In the model portfolio — top-12 twelve-month momentum, trading above its 200-day average.
- Signal has read STRONG BUY for 2 months.
- Its last 3 Buy calls have averaged +77% over the following quarter.
- Recent price momentum is +239.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 29.2% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 11.34
- Open
- 11.28
- Day range
- 11.15 - 11.54
- Avg price
- 11.36
- Volume
- 3.14M
- Turnover
- 35.68M
- Turnover ratei
- 1.56%
- Volume ratioi
- 0.57
- Amplitudei
- 3.48%
- 52-week rangei
- 1.39 - 15.88
Valuation
- P/Ei
- -45.24
- P/E (TTM)i
- -51.41
- P/Bi
- 16.58
- EPSi
- -0.25
- Book value / shi
- 0.68
- Net profit
- -50.49M
- Net assets
- 137.73M
Share structure
- Market cap
- 2.28B
- Float capi
- 2.27B
- Shares out
- 201.95M
- Float sharesi
- 201.15M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
28.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-46.38M net over the window
Short interest
- Shares short
- 59.07M
- % of floati
- 29.25%
- Days to coveri
- 8.60
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Sellas Life Sciences (SLS)?
Sellas Life Sciences last traded at 11.31. The quote on this page refreshes every few seconds while US markets are open.
What is Sellas Life Sciences's market cap?
About 2.28B.
What is the P/E ratio of Sellas Life Sciences?
The trailing twelve-month P/E is -51.41. The Valuation tab shows it against the stock's own five-year range.
Does Sellas Life Sciences pay a dividend?
Sellas Life Sciences does not currently pay a regular dividend.
Is Sellas Life Sciences a buy according to analysts?
The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 30.00, which implies 165.3% upside from the current price. This is not investment advice.
What is Sellas Life Sciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Sellas Life Sciences a A (Strong Buy). In the model portfolio — top-12 twelve-month momentum, trading above its 200-day average. Not investment advice.
Quote time 2026-10-08 06:26:32 · For reference only, not investment advice and not tailored to your situation.